Association between common variants near the melanocortin 4 receptor gene and severe antipsychotic drug-induced weight gain
about
Decoding the non-coding genome: elucidating genetic risk outside the coding genomePharmacogenetics and outcome with antipsychotic drugsGenetics of Common Antipsychotic-Induced Adverse EffectsTreatment-resistant schizophrenia: current insights on the pharmacogenomics of antipsychoticsProgress in understanding the genomic basis for adverse drug reactions: a comprehensive review and focus on the role of ethnicityMC4R rs489693: a clinical risk factor for second generation antipsychotic-related weight gain?Schizophrenia.Molecular substrates of schizophrenia: homeostatic signaling to connectivityTowards the clinical implementation of pharmacogenetics in bipolar disorder.Comparative efficacy and safety of antipsychotics in the treatment of schizophrenia: a network meta-analysis in a Japanese population.Pharmacogenetics of antipsychotics.Identification of candidate single-nucleotide polymorphisms in NRXN1 related to antipsychotic treatment response in patients with schizophrenia.The role of leptin, melanocortin, and neurotrophin system genes on body weight in anorexia nervosa and bulimia nervosa.Managing cardiovascular disease risk in patients treated with antipsychotics: a multidisciplinary approachAssociation between MC4R rs17782313 polymorphism and overeating behaviors.Positive perception of pharmacogenetic testing for psychotropic medicationsAripiprazole for the management of schizophrenia in the Japanese population: a systematic review and meta-analysis of randomized controlled trials.Genome-wide association studies in Africans and African Americans: expanding the framework of the genomics of human traits and disease.Pharmacogenetics of clozapine treatment response and side-effects in schizophrenia: an update.Influence of MCHR2 and MCHR2-AS1 Genetic Polymorphisms on Body Mass Index in Psychiatric Patients and In Population-Based Subjects with Present or Past Atypical Depression.Taking Personalized Medicine Seriously: Biomarker Approaches in Phase IIb/III Studies in Major Depression and SchizophreniaRecent advances in understanding and mitigating adipogenic and metabolic effects of antipsychotic drugs.An Economic Evaluation of a Weight Loss Intervention Program for People with Serious Mental Illnesses Taking Antipsychotic MedicationsPharmacogenetics of antipsychotics: recent progress and methodological issues.Genetic variants associated with response to lithium treatment in bipolar disorder: a genome-wide association studyGenome-Wide Association Study Suggested the PTPRD Polymorphisms Were Associated With Weight Gain Effects of Atypical Antipsychotic Medications.Is Metabolic Syndrome On the Radar? Improving Real-Time Detection of Metabolic Syndrome and Physician Response by Computerized Scan of the Electronic Medical RecordModeration of antipsychotic-induced weight gain by energy balance gene variants in the RUPP autism network risperidone studies.Genes and schizophrenia: from a Festschrift Seminar honoring William T. Carpenter Jr, MD.Cardiometabolic outcomes in children and adolescents following discontinuation of long-term risperidone treatment.TOX and ADIPOQ Gene Polymorphisms Are Associated with Antipsychotic-Induced Weight Gain in Han Chinese.Weight gain and increase of body mass index among children and adolescents treated with antipsychotics: a critical review.Novel "thrifty" models of increased eating behaviour.Pharmacogenetics in schizophrenia: a review of clozapine studies.Clinical validity of cytochrome P450 metabolism and serotonin gene variants in psychiatric pharmacotherapy.Safety profile of iloperidone in the treatment of schizophrenia.Genetics of antipsychotic-induced weight gain: update and current perspectives.Individualizing clozapine and risperidone treatment for schizophrenia patients.Directions for future patient-centered and comparative effectiveness research for people with serious mental illness in a learning mental health care systemPharmacogenetics of second-generation antipsychotics.
P2860
Q26777924-DF5A2468-D4F7-4908-B8F7-9BAB610243A0Q26852807-2273E20B-5B00-4437-8495-2DCC018C7C9DQ28072893-BBF03E0D-F41A-406C-9989-B4B5EDCBE679Q28079065-4BE80EBA-180B-4FC6-AB3D-A8AE02808AB2Q28083100-45D22B7F-2798-4E12-BAC8-BC2AEF37BAEEQ28296094-B8798DF0-36F5-4C95-A758-42C62E231B7FQ30251961-6EA2D1FB-5A32-43EC-8F83-BFF3450D339BQ30383611-B185479D-CD5A-40E2-87BF-9F808BF15AD7Q33688133-84C4C20E-955C-44E5-B266-F2116FEF4799Q33713759-867ABB4B-4370-441C-B666-7AF89CA90F80Q33836837-5F3CA549-2A0D-4BEF-95B3-98C07435325CQ33923615-11B2F2BE-68D6-4635-AA33-2E047AED8EF2Q34315012-12A5240A-8402-4D7D-8DDB-9A16E50F81D7Q34464293-EC674DE2-8320-429F-B683-E2DCFB8FC708Q34514174-4BCBE497-834C-4BAE-B87C-44B5462656AAQ34541288-1AA2EE7E-1E95-425B-B701-1FBCBA4EB64EQ35136085-D8BD28D5-220C-42D9-BBF1-F95843F4F8E9Q35565624-72F8BBC1-2D74-48D1-A5CE-5538ADFAE469Q35771833-38D0CE99-34E5-4CAE-BCE4-D09ADE7865C9Q35804713-1F149616-B286-40D5-AE01-13202132579EQ36063627-424A65C1-88D8-4E74-A907-4EB6B1D5A91BQ36063735-06163CEE-0AB1-4609-8FDB-62608EA442A8Q36441253-E1DEC3C5-339C-4713-8AF1-B83C922353E4Q36539833-602A28D5-F395-4D10-BF31-63AE1F97AD81Q36746449-AA5C6DAF-7067-460E-9D34-A6C03B235AA6Q36817242-355BA066-60AB-42B7-9B3E-E37F48C108F6Q36921831-77633D06-0E42-45AC-A0C1-066ED15F2AF6Q36956632-0B040F3E-C11C-4203-9D9A-D91A9CE1781EQ37602618-F655888E-5174-434B-A72E-A48365C397EFQ37712697-3808E4B4-C876-4B6C-9478-C61121147339Q37714911-01AFCB95-AB9F-4DA6-B6A5-8C862C708AFAQ38090490-9216C04A-1113-4FC5-A297-1E1FEA9D3CA1Q38140664-55C09EC7-AAF2-466D-897F-E89A3958DF92Q38154175-4F861FC9-CF74-46CA-AA46-0A9759B9FFCCQ38154911-EA3F369A-D264-4218-BF3E-FA0F81FC5894Q38160942-C3882295-57D5-420A-894C-ECC41838DC0EQ38166456-0B08B167-C141-4575-AD1C-60CB23E70380Q38170458-92485D76-D11D-4376-A403-A71D5D1D07B8Q38184528-A683F07B-4730-44AA-B165-E88EFC629759Q38217628-375DC9EF-EE8F-4577-B4AF-7CDFE9B47B8B
P2860
Association between common variants near the melanocortin 4 receptor gene and severe antipsychotic drug-induced weight gain
description
2012 nî lūn-bûn
@nan
2012 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Association between common var ...... hotic drug-induced weight gain
@ast
Association between common var ...... hotic drug-induced weight gain
@en
Association between common var ...... hotic drug-induced weight gain
@nl
type
label
Association between common var ...... hotic drug-induced weight gain
@ast
Association between common var ...... hotic drug-induced weight gain
@en
Association between common var ...... hotic drug-induced weight gain
@nl
prefLabel
Association between common var ...... hotic drug-induced weight gain
@ast
Association between common var ...... hotic drug-induced weight gain
@en
Association between common var ...... hotic drug-induced weight gain
@nl
P2093
P2860
P50
P3181
P1433
P1476
Association between common var ...... hotic drug-induced weight gain
@en
P2093
Anil K Malhotra
Annette T Lee
Arun K Tiwari
Christoph U Correll
Daniel J Müller
Herbert Y Meltzer
James L Kennedy
John M Kane
Nabilah I Chowdhury
Roel A Ophoff
P2860
P304
P3181
P356
10.1001/ARCHGENPSYCHIATRY.2012.191
P407
P577
2012-09-01T00:00:00Z